These results support previous findings that PAF-PAFR signaling pathway could synergistically be activated with tyrosine kinase -VEGFR pathway to modulate the abnormal proliferation in ovarian cancer [48, 49]. The gene discussed is KDR; the disease is ovarian carcinoma.